Stocks

The table gives an overview of all stocks, alphabetically sorted.
 K-Fast Holding B KFASTB Feb 19, 2020 179.60 0.00   
 K2A Knaust & Andersson Fastigh K2APREF Feb 19, 2020 352.00 +0.28   
 K2A Knaust & Andersson Fastigh K2AB Feb 19, 2020 169.60 +3.79   
 KABE Group B KABEB Feb 19, 2020 147.00 -1.01   
 Kakel Max KAKEL Feb 19, 2020 11.70 +0.86   
 Kallebäck Property Invest KAPIAB Feb 19, 2020 181.00 -2.95   
 Kambi Group KAMBI Feb 19, 2020 163.00 +2.52   
 Kancera KAN Feb 19, 2020 0.56 +4.70   
 Karessa Pharma Holding KARE Feb 19, 2020 2.62 -3.68   
 Karnov Group KAR Feb 19, 2020 57.00 +0.89   
 Karo Pharma KARO Feb 19, 2020 44.64 +0.09   
 Karolinska Development B KDEV Feb 19, 2020 3.85 +0.52   
 Kentima Holding B KENH Feb 19, 2020 1.21 +2.55   
 Kid KIDO Feb 19, 2020 56.60 0.00   
 Kindred Group SDB KINDSDB Feb 19, 2020 56.20 +0.68   
 Kinnevik A KINVA Feb 19, 2020 235.50 +0.86   
 Kinnevik B KINVB Feb 19, 2020 232.90 +1.22   
 Kitron KITO Feb 19, 2020 12.00 0.00   
 Klaria Pharma Holding KLAR Feb 19, 2020 5.28 +3.94   
 Klövern A KLOVA Feb 19, 2020 26.40 +3.94   
 Klövern B KLOVB Feb 19, 2020 26.52 +4.41   
 Klövern Pref KLOVPREF Feb 19, 2020 376.00 -0.66   
 Knowit KNOW Feb 19, 2020 192.00 +1.69   
 Kollect on Demand Holding KOLL Feb 19, 2020 9.88 0.00   
 Komplett Bank KOMPO Feb 19, 2020 7.75 0.00   
 Kongsberg Automotive ASA KOAO Feb 19, 2020 4.91 +0.20   
 Kongsberg Gruppen KOGO Feb 19, 2020 172.50 0.00   
 Kontigo Care KONT Feb 19, 2020 3.93 -2.24   
 Kopparbergs B KOBRB Feb 19, 2020 167.00 +0.72   
 Kopy Goldfields KOPY Feb 19, 2020 0.94 +1.95   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK